Drugs / Bifidobacterium lactis HN019
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00255385 | Apr 2002 → Apr 2004 | diarrheal disease, pneumonia | Johns Hopkins Bloomberg School of Public Health | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifidobacterium lactis HN019 | “adding prebiotic oligosaccharide and probiotic Bifidobacterium lactis HN019 to milk” PMID 20730056 ↗ Aug 2010 |
| Modality | Other / unclassified | “probiotic Bifidobacterium lactis HN019” PMID 20730056 ↗ Aug 2010 |
| Route | Oral | “same milk fortified with 2.4 g/day of prebiotic oligosaccharide and 1.9x10(7) colony forming unit (c.f.u)/day of probiotic Bifidobacterium lactis HN019” PMID 20730056 ↗ Aug 2010 |